SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr Reddys Laboratories clarifies on news item

28 Sep 2015 Evaluate

With reference to the news reported in (MINT 26/09/2015) - ‘Dr. Reddys to buy IP rights of Alchemias fondaparinux drug for Rs 116 cr’, Dr Reddys Laboratories has clarified to observation on today’s movement of their share price, in their opinion, is due to the approval by the US FDA and subsequent launch of our high value generic Esomeprazole product in the US market. They would also like to clarify that the aforementioned news article regarding purchase of IP rights for Alchemia drug at Rs 116 cr is a transaction in the regular course of the business. They already have an existing technology licensing agreement with Alchemia. Proposed transaction just represents a conversion of the said licensing agreement into a proposed IP ownership structure. At this stage they have only signed a binding term sheet with the party and a definitive agreement has not yet been reached. Further, they believe that the impact of this transaction is not material to its operations, warranting stock exchange intimation under clause 36 of the Listing Agreement.

The above information is a part of company’s filings submitted to BSE.

Dr. Reddys Labs. Share Price

1374.55 28.30 (2.10%)
03-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1904.65
Dr. Reddys Labs. 1374.55
Cipla 1458.45
Zydus Lifesciences 1141.00
Lupin 2476.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: